SEC Form 4 · accession 0001078782-18-000006
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Dec 22, 2017
Accepted (ET)
Jan 4, 2018 · 3:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 22, 2017 | P | 35,000 | $0.11 | A | 14,172,831 | D | |
| Common Stock | Dec 29, 2017 | P | 20,000 | $0.09 | A | 14,192,831 | D | |
| Common Stock | Jan 3, 2018 | P | 48,000 | $0.08 | A | 14,240,831 | D |
Table II — derivative securities
No Table II lines on this filing.